A Case of Early Disseminated Neurological Lyme Disease Followed by Atypical Cutaneous Manifestations

Case Reports in Infectious Diseases
Vamsi KantamaneniScott Vargo

Abstract

Lyme disease (LD) is a tick-borne illness caused by Borrelia burgdorferi sensu stricto. An 80-year-old female from Pennsylvania, USA, presented to an outside hospital with fever, confusion, lower extremity weakness, and stool incontinence. CT head and MRI spine were unremarkable. An infectious work-up including lumbar puncture was negative. She was transferred to our tertiary care hospital. Patient was noted to have mild unilateral right-sided facial droop and a diffuse macular rash throughout the body. She denied any outdoor activities, tick bites, or previous rash. Intravenous ceftriaxone was started for suspected LD. The patient's symptoms including facial droop resolved within 24 hours of antibiotic therapy. Polymerase chain reaction of the blood, IgM ELISA, and IgM Western blot testing for LD came back positive a few days after initiation of therapy. She was treated for a total of 21 days for neurological LD with complete symptom resolution. Not all patients have the classic "targetoid" EM rash on initial presentation, rash could develop after neurological manifestations, and prompt initiation of antibiotics without awaiting serology is paramount to making a quick and a full recovery. There should be a high index of suspic...Continue Reading

References

Nov 22, 1990·The New England Journal of Medicine·E L LogigianA C Steere
Nov 25, 2003·Lancet·Gerold Stanek, Franc Strle
May 4, 2005·Annals of Internal Medicine·Gary P WormserJohn Nowakowski
Mar 7, 2009·Journal of the American Board of Family Medicine : JABFM·Candis MorrisonJohn N Aucott
Jan 11, 2013·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Natalie PeetersDavid R Colnot
May 23, 2013·Critical Care Nursing Clinics of North America·Maria L Overstreet
Mar 7, 2014·BMJ Case Reports·Raman Mehrzad, Joseph Bravoco
May 3, 2014·The New England Journal of Medicine·Eugene D Shapiro
Jun 27, 2014·Arthritis & Rheumatology·Linda K Bockenstedt, Gary P Wormser
Dec 3, 2014·Journal of Autoimmunity·Andrea T BorchersM Eric Gershwin
Apr 13, 2015·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Esther C YoonJohn T Fallon
May 29, 2015·The New England Journal of Medicine·Nora Regelin, Ernesto Montaruli
Sep 9, 2015·Journal of Cutaneous Pathology·Allen P MiraflorShaofeng Yan

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
PCR
ELISA

Related Concepts

Related Feeds

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.